Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effective drugs or dosing regimens are limited. To better identify treatment approaches and associated toxicities, we collected a series of case reports from the Emerging Infections Network. Side effects were common and often led to changing or discontinuing therapy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766900 | PMC |
http://dx.doi.org/10.3201/eid2203.150828 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!